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Summary
Increasing emergence of drug-resistant microorgan-
isms poses a great concern to clinicians; thus, new
active products are urgently required to treat a num-
ber of infectious disease cases. Different metallic
and metalloid nanoparticles have so far been
reported as possessing antimicrobial properties and
proposed as a possible alternative therapy against
resistant pathogenic microorganisms. In this study,
selenium nanoparticles (SeNPs) synthesized by the
environmental bacterial isolate Stenotrophomonas
maltophilia SeITE02 were shown to exert a clear
antimicrobial and antibioﬁlm activity against different
pathogenic bacteria, either reference strains or clini-
cal isolates. Antimicrobial and antibioﬁlm capacity
seems to be strictly linked to the organic cap sur-
rounding biogenic nanoparticles, although the actual
role played by this coating layer in the biocidal action
remains still undeﬁned. Nevertheless, evidence has
been gained that the progressive loss in protein and
carbohydrate content of the organic cap determines
a decrease in nanoparticle stability. This leads to an
alteration of size and electrical properties of SeNPs
along with a gradual attenuation of their antibacterial
efﬁcacy. Denaturation of the coating layer was
proved even to have a negative effect on the antibio-
ﬁlm activity of these nanoparticles. The pronounced
antimicrobial efﬁcacy of biogenic SeNPs compared
to the denatured ones can – in ﬁrst instance – be
associated with their smaller dimensions. This study
showed that the native organic coating layer of bio-
genic SeNPs functions in avoiding aggregation and
maintaining electrostatic stability of the nanoparti-
cles, thus allowing them to maintain efﬁcient antimi-
crobial and antibioﬁlm capabilities.
Introduction
In the last decades, widespread antibiotic treatment of
clinical cases due to bacterial and fungal infections has
become a threat because of increasing occurrence of
antimicrobial resistance (AMR) within microorganisms
that are often able to form fastidious bioﬁlms on tissues
and medical devices (Penesyan et al., 2015). Both
aspects represent a serious concern as available antimi-
crobial drugs have proved to be poorly active or inefﬁca-
cious giving rise to the emergence of chronic infections
and an increase in morbidity and death rate. This has
led to a growing awareness that new approaches,
including those based on the use of non-antibiotic
antibacterial agents, need to be perfected to face the
antibiotic resistance challenge (Beyth et al., 2015).
In this perspective, tailored metal nanoparticles (NPs)
have recently come to the forefront as promising antibac-
terial and antibioﬁlm agents (Rizzello and Pompa, 2014;
Shakibaie et al., 2015). For instance, silver nanoparticles
(AgNPs), one of the most studied classes of NPs, have
been extensively considered in the last two decades as
antimicrobial and anticancer agent drug delivery systems
as well as in diagnostics and probing for the treatment of
various diseases (Yuan et al., 2017). AgNPs are likely to
exert their antibacterial effects in a dose- and time-
dependent manner. Moreover, silver nanoparticles have
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been demonstrated able to perform their antibacterial
activity through the generation of reactive oxygen spe-
cies (ROS), production of malondialdehyde (MDA), and
leakage induction of proteins and sugars from bacterial
cells (Yuan et al., 2017). Although the mechanisms
underlying the antibacterial effect of metal NPs have not
yet been elucidated, it is generally believed that induc-
tion of oxidative stress, release of metal ions and/or non-
oxidative reactions are involved (Wang et al., 2017).
According to the information available from previous
investigations, the major processes by which NPs exert
antibacterial activity can be summarized as follows: (i)
penetration into and disruption of bacterial cell mem-
brane, (ii) generation of ROS and (iii) induction of harm-
ful intracellular reactions, including damages on DNA
and proteins (Wang et al., 2017).
Recently, Cremonini et al. (2016) reported on compar-
ative tests carried out with selenium nanoparticles
(SeNPs) of biogenic nature, produced by two environ-
mental bacterial strains [namely, Bacillus mycoides
SeITE01 and Stenotrophomonas maltophilia (SeITE02)
and chemically synthesized selenium nanoparticles (Ch-
SeNPS)]. Biogenic SeNPs showed a higher antibacterial
activity against a number of clinical strains of Pseu-
domonas aeruginosa as well as a signiﬁcant inhibition of
bioﬁlm formation along with disaggregation capacity
towards already established bacterial bioﬁlms. Further-
more, biogenic SeNPs showed no toxic effects in cell
cultures of human dendritic cell (DCs) or ﬁbroblasts and
did not elicit production of pro-inﬂammatory and immune-
stimulatory cytokines (Cremonini et al., 2016).
By relying on these results, the aim of this study was
to investigate a possible wider antimicrobial activity of
SeNPs from S. maltophilia SeITE02 against an extended
list of bacterial species and strains, with attention to
speciﬁc factors that could play a role in modulating the
efﬁcacy of such nanoparticles. In particular, we focused
on the possible variations in antimicrobial and antibioﬁlm
capacity of SeNPs as a consequence of the denatura-
tion of their organic coating layer.
Results
Biosynthesis and structural features of selenium
nanoparticles
As reported in previous studies (Jain et al., 2015; Cre-
monini et al., 2016; Lampis et al., 2017), biogenic SeNPs
from the bacterial strain Stenotrophomonas maltophilia
SeITE02 present a complex organic cap consisting of dif-
ferent biomolecules such as proteins, lipids and carbohy-
drates. In order to evaluate the possible inﬂuence of such
an organic coating layer on the biological reactivity of
these biogenic SeNPs (here called SeNPs-24 and also
untreated SeNPs), different and progressively more
aggressive denaturants were applied to the nanoparticles.
Quantiﬁcation of surface-associated macromolecular
matrix as well as measurement of physical and electrical
properties was performed on untreated and differently
treated SeNPs.
Figure 1A shows how the protein content associated
with the organic coating layer of SeNPs decreases after
exposure to the different denaturing agents. The concen-
tration of proteins associated with untreated biogenic
SeNPs is 0.46  0.05 mg mg1 NPs; this value progres-
sively decreases to 0.05  0.01 mg mg1 NPs after
exposure to the most drastic denaturation by means of
10% sodium dodecyl sulphate (SDS) and 30-min boiling.
A similar pattern was observed for carbohydrate concen-
tration (Fig. 1B) with untreated biogenic SeNPs showing
a value of 0.33  0.04 mg mg1 NPs that then fell to
0.02  0.01 mg mg1 NPs after the strongest denatur-
ing treatment.
Dynamic light scattering measurements (Table 1)
showed an average size for untreated biogenic SeNPs
Fig. 1. Protein (A) and carbohydrate (B) content of SeNPs as bio-
genic product and after different treatments (n = 3; P < 0.05).
Untreated: biogenic SeNPs; Treatment 1: 10% SDS; Treatment 2:
10% SDS+10 min boiling; Treatment 3: 10% SDS+30 min boiling.
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of 181  20 nm with a Z-potential value of 32.01 mV.
Exposure to different denaturing treatments caused a
progressive growth of nanoparticle dimensions, up to
270  24 nm after the treatment with 10% SDS and 30-
min boiling. In particular, as shown in Fig. S1, the pro-
gressively more denaturing treatment of biogenic NPs
resulted in an increase in the number of SeNPs of larger
size and more susceptible to aggregate each other. On
the other hand, values of the Z-potential of SeNPs ran-
ged within 17.40 and 3.97 mV after different denatur-
ing procedures (Table 1).
Another type of SeNPs (SeNPs-48) was also taken
into consideration: these SeNPs were obtained from
bacterial cultures after 48 h of incubation with sodium
selenite and showed a diameter of 276  26 nm, with a
Z-potential value of 29.27 mV (Fig. S2A and B). The
protein concentration associated with these biogenic
nanostructures was 0.48  0.07 mg mg1 SeNPs,
while the carbohydrate concentration was 0.35 
0.03 mg mg1 SeNPs (Fig. S2C).
Antimicrobial activity of SeNPs in different
conformational states
A number of bacterial strains belonging to different spe-
cies were screened for the susceptibility to untreated
and treated SeNPs. These bacterial species/strains were
selected based on their actual occurrence in bioﬁlm-
mediated infections. Therefore, Pseudomonas aerugi-
nosa and Burkholderia cenocepacia as well as emerging
harmful pathogens such as Achromobacter xylosoxidans
and Stenotrophomonas maltophilia causing chronic lung
infections in cystic ﬁbrosis and immunodepressed
patients (Bjarnsholt, 2013) were taken into account. On
the other hand, as far as Gram-positive bacterial agents
are concerned, staphylococci were considered important
producers of bioﬁlms associated with the implantation of
biomedical devices or skin pathologies (Paharik and Hor-
swill, 2016).
As shown in Table 2, MIC values of biogenic SeNPs
varied widely among the different microbial species and
even diverse strains belonging to the same species,
ranging from 4 to 128 lg ml1. Nevertheless, an evalua-
tion of the activity of SeNPs on the different bacterial
strains tested (in terms of susceptibility or resistance)
turned out to be quite difﬁcult as standard break points
do not exist and a comparison with the susceptibility to
antibiotics is not predictable. Two groups of strains could
be distinguished: one showing low values of MIC (4–
16 lg ml1) while the other showing higher MIC values
(32–128 lg ml1), although a strict association with
speciﬁc bacterial species or even families cannot be
done. For instance among P. aeruginosa strains, PAO1
and BR2 showed low values of MIC while in INT and
BR1 higher MIC values were measured. The same was
also demonstrated for Staphylococcus aureus, Mu50
strain showing the highest MIC value of 128 lg ml1. As
a general rule, it seems that Gram-positive strains
responded to SeNPs with lower MIC values when com-
pared to the Gram-negative ones. Anyway, the number
of bacterial strains studied so far is too restricted to con-
ﬁrm such a trend. To evaluate the inﬂuence by the whole
organic cap of biogenic selenium nanoparticles on their
antimicrobial efﬁcacy, such an activity was tested with
nanoparticles subjected to progressively stronger proto-
cols for the denaturation of the external organic coating.
Data reported in Table 2 show, for almost all the strains
screened, a decrease in the antimicrobial activity of
SeNPs, which experienced the most intensive denatura-
tion, as revealed by progressively higher MIC values.
To evaluate the bioactivity of SeNPs still surrounded
by an intact organic cap with those of similar size but
extensively denatured, SeNPs-48 were tested against
those strains that had shown the highest MIC values
against denatured SeNPs, namely P. aeruginosa PAO1,
P. aeruginosa BR2, S. maltophilia VR20 and S. aureus
UR1. As reported in Fig. S2D, the MIC values for
SeNPs-48 were lower than those registered with most
extensively denatured SeNPs, ranging between 16 and
256 lg ml1 with reference to the different bacterial
strains tested.
Antibioﬁlm activity of SeNPs in different conformational
states
Efﬁcacy of both untreated and denatured SeNPs in pre-
venting bacterial bioﬁlm formation or promoting bioﬁlm
eradication was also evaluated. Tests were carried out
on a selection of bacterial strains, namely PAO1, BR1
and BR2 of P. aeruginosa, B. cenocepacia and the
S. haemolitycus. The choice was made on the basis of
low MIC values for SeNPs shown by the respective
planktonic cultures and the high capacity of bioﬁlm for-
mation of these strains. On the other hand, S. aureus
Mu50 showing methicillin resistance as well as being
known as moderately resistant to vancomycin was also
Table 1. Dynamic light scattering analysis and zeta potential of
SeNPs as biogenic product and after different treatments (n = 3;
average  SD). Untreated: biogenic SeNPs; Treatment 1: 10%
SDS; Treatment 2: 10% SDS + 10 min boiling; Treatment 3: 10%
SDS + 30 min boiling.
Diameter (nm) Ζ-potential (mV)
Untreated SeNPs 181  20 32.01  2.67
Treatment 1 209  25 17.40  3.45
Treatment 2 233  19 8.11  2.36
Treatment 3 270  24 3.97  1.34
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taken into consideration as a bacterial strain able to with-
stand the presence of antibiotics and SeNPs. By relying
on the results of preliminary tests (data not shown), anti-
bioﬁlm activity of SeNPs in different conformational
states was measured at a nanoparticle concentration of
128 lg ml1, found as the lowest concentration with a
signiﬁcant contrasting effect on bioﬁlm formation.
Quantiﬁcation of the total bioﬁlm biomass singularly
formed by the six bacterial strains tested was obtained
through crystal violet (CV) staining. Afterwards, counts of
viable cells (reported as CFU ml1) still present within
bioﬁlm matrices were determined by plating aliquots of
bioﬁlms on an agarized growth substrate. Exposure of
bioﬁlms produced by all P. aeruginosa strains tested to
128 lg ml1 of SeNPs in their different conformational
states resulted in a clear decrease in the CV signal. This
effect was more pronounced with untreated biogenic
SeNPs rather than with most extensively denatured
SeNPs (Fig. 2A). Culturable cells of P. aeruginosa
PAO1 decreased signiﬁcantly after treatments with differ-
ent types of SeNPs with the exception of those harshly
denatured (Fig. 2B). On the other hand, the number of
CFU ml1 counted from bioﬁlms of P. aeruginosa BR1
and BR2 decreased signiﬁcantly only in case of expo-
sure to untreated SeNPs (Fig. 2B). Moreover, it is worth
noting that the bioﬁlm generated by B. cenocepacia
LMG 16656 was quite susceptible to degradation by all
conformational types of SeNPs, including most exten-
sively denatured nanoparticles. Numbers of culturable
cells recovered from bioﬁlms of this strain, exposed to all
kind of SeNPs, were signiﬁcantly lower than those from
control bioﬁlms (Fig. 3).
As far as strain Mu50 of S. aureus is concerned,
despite the low susceptibility to the action of SeNPs in
planktonic state (MIC of 128 lg ml1), its bioﬁlm
depositions were easily degradable by all forms of
SeNPs tested. A decrease in the number of culturable
cells associated with the bioﬁlm matrix was observed
after treatment with selenium nanoparticles. The lowest
effects were, however, revealed when most denatured
SeNPs were applied. Finally, S. haemolyticus UST1 that
synthesizes a very SeNP-resistant bioﬁlm did not show
any decrease in the number of culturable cells after
exposure to all the NPs tested (Fig. 3).
The comparison of the effects on bioﬁlm biomass and
cell viability between the different types of SeNPs tested
(Figs 2 and 3) showed a difference not only in terms of
the control but also among the various denaturing treat-
ments applied to the NPs. In all the strains tested,
except for the S. haemolyticus UST1 strain, the progres-
sive denaturation of the surface biomolecular cap is
related to a loss of their antibioﬁlm activity shown by an
increasing value of CV signal and increasing number of
CFU ml1. The statistic analysis reported, indeed, points
out a signiﬁcant difference in particular between the anti-
bioﬁlm activity of the untreated NPs and the ones
exposed to the harshly denaturing treatment.
Role of reactive oxygen species induced by SeNPs
Reactive oxygen species (ROS) are important elements
in the bacterial response to physical and chemical envi-
ronmental stresses and have been associated with the
killing action of a variety of antimicrobial agents (Van
Acker and Coenye, 2017). The production of ROS in
response to treatment with biogenic SeNPs was anal-
ysed in P. aeruginosa PAO1, S. aureus Mu50 and
B. cenocepacia LMG16656 strains. As shown in Fig-
ure 4, in all bacterial strains tested an increase in ROS
Table 2. Minimum inhibitory concentration (MIC) of different types of SeNPs against various bacterial strains. Untreated: biogenic SeNPs;
Treatment 1: 10% SDS; Treatment 2: 10% SDS + 10 min boiling; Treatment 3: 10% SDS + 30 min boiling. Data are expressed as the average
of three biological replicates.
Bacterial species Strain name
MIC lg ml1
Untreated SeNPs Treatment 1 Treatment 2 Treatment 3
P. aeruginosa PAO1 8 16 128 64
P. aeruginosa INT 64 512 > 512 > 512
P. aeruginosa BR1 32 64 32 64
P. aeruginosa BR2 8 16 32 128
S. maltophilia VR10 32 16 32 64
S. maltophilia VR20 64 256 512 > 512
A. xylosoxidans C 64 > 512 > 512 > 512
B. cenocepacia LMG16656 16 16 32 32
S. aureus Mu50 128 128 256 512
S. aureus UR1 4 16 32 64
S. haemolyticus UST1 16 8 32 64
S. epidermidis ET024 4 8 16 64
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produced after treatment with biogenic nanoparticles
was observed compared to the untreated controls.
Discussion
Over the last two decades, several authors have made
increasing efforts to develop innovative antimicrobial
agents based on metal/metalloid nanostructured particles
as an alternative strategy to overcome the worrisome
increase in antibiotic resistance. Antibiotic-resistant infec-
tions are in fact more and more widespread, particularly in
nosocomial contexts. The emergence of such pathogenic
conditions generates in turn further risks due to the
recourse to higher doses of drugs or additional toxic thera-
peutic treatments which can be responsible for longer
hospital stays and an increased death rate (Ferri et al.,
2015). Major concerns are associated in this respect with
multidrug resistance (MDR) bacteria and bioﬁlm-forming
microbial communities.
In this scenario, selenium nanoparticles either of bio-
genic origin or chemically synthesized have been proven
to possess surprising antibacterial and antibioﬁlm capa-
bilities (Cihalova et al., 2015; Cremonini et al., 2016;
Huang et al., 2016).
Fig. 2. Antibioﬁlm activity of different types of SeNPs measured by CV staining (effect on bioﬁlm biomass) (A) and colony counting (effect on
cell viability) (B), as regards P. aeruginosa strains PAO1, BR1 and BR2 (n = 3, Average  SEM). #P < 0.05 compared to a bioﬁlm grown in
the absence of SeNPs (Control); *P < 0.05 compared to a bioﬁlm treated with ‘untreated SeNPs’. Untreated: biogenic SeNPs, Treatment 1:
10% SDS, Treatment 2: 10% SDS + 10 min boiling, Treatment 3: 10% SDS+30 min boiling.
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The present study focused on the inﬂuence that the
outer organic coating layer of biogenic SeNPs synthe-
sized by the bacterial strain S. maltophilia SeITE02
(Zonaro et al., 2015; Lampis et al., 2017) plays in
determining antimicrobial and antibioﬁlm efﬁcacy of
such nanostructured particles. Actually, biogenic SeNPs
produced by the strain SeITE02 are surrounded by an
organic cap mainly consisting of proteins, lipids and
carbohydrates (Cremonini et al., 2016; Lampis et al.,
2017). Four different types of biogenic elemental sele-
nium nanoparticles obtained as a result of 24-h
incubation of S. maltophilia SeITE02 in the presence of
selenite were considered according to the follow
scheme: (i) untreated SeNPs as well as the same bio-
genic nanoparticles subjected, however, to increasingly
stronger denaturing procedures, namely (ii) denatured
through a treatment with 10% SDS, (iii) treated with
10% SDS and 10-min boiling, and (iv) strongly dena-
tured with 10% SDS and 30-min boiling. By increasing
the strength of denaturing treatments, a progressive
loss of proteins and carbohydrates from the organic
coat surrounding SeNPs was shown along with an
Fig. 3. Antibioﬁlm activity of different types of SeNPs measured by CV staining (effect on bioﬁlm biomass) (A) and colony counting (effect on
cell viability) (B), as regards B. cenocepacia LMG 16656, S. aureus Mu50 and S. haemoliticus UST1 (n = 3, Average  SEM). # P < 0.05 com-
pared to a bioﬁlm grown in the absence of SeNPs (Control); * P < 0.05 compared to a bioﬁlm treated with ‘untreated SeNPs’. Untreated: bio-
genic SeNPs, Treatment 1: 10% SDS, Treatment 2: 10% SDS + 10 min boiling, Treatment 3: 10% SDS + 30 min boiling.
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increment in nanoparticle size and a change in their Z-
potential.
Growth in size of biogenic selenium nanoparticles as
a consequence of denaturation due to partial loss of the
external coating layer was an expected result as this
phenomenon is widely reported in the literature (Dobias
et al., 2011). Therefore, the presence of an organic cap
surrounding biogenic SeNPs conﬁrmed its pivotal role in
preventing particle aggregation. Furthermore, the shift of
Z-potential measurements towards less negative values
also reduced the stability of untreated SeNPs. It is in fact
well known that NPs with charges close to a neutral
value tend to coalesce (Hunter, 1981). Moreover, antimi-
crobial activity of each type of SeNPs tested against dif-
ferent bacterial pathogens was quantiﬁed by MIC value
determination. Results showed a wide variability of bac-
terial response to distinct kind of SeNPs as regards this
parameter not only among different species but also
within strains belonging to the same species. Despite
this variable antimicrobial efﬁcacy of untreated SeNPs
towards the different bacterial strains tested, as a gen-
eral rule MIC values increased with the progressive
denaturation of the organic coating layer. These ﬁndings
suggest that antimicrobial activity of SeNPs is size-
dependent, with higher inhibiting effects associated with
the smallest ones, as already reported in previous stud-
ies (Lu et al., 2013; Chudobova et al., 2014; Zonaro
et al., 2015). Indeed, denaturation of the external organic
cap which leads to a progressive increase in particle
dimensions coincides with a gradual drop in antibacterial
efﬁcacy. Nevertheless, also variations in the qualitative
and quantitative features of the organic coating seem to
affect the antimicrobial properties of SeNPs biosynthe-
sized by S. maltophilia SeITE02. To verify a direct inﬂu-
ence of the organic layer surrounding these nanoparticles
on their biocidal potential, SeNPs from strain SeITE02 cul-
tures after a 48-h incubation (SeNPs-48), larger in size than
those recovered from a 24-h culture (SeNPs-24) but with
similar size to the strongly denatured ones, were tested
against the bacterial strains that have shown to withstand
the highest MIC values. Interestingly, these biogenic
SeNPs-48 owning their native surrounding layer showed
MIC values signiﬁcantly lower than those detected with
more extensively denatured SeNPs. Therefore, based on
these observations, it can be argued that the organic cap
surrounding biogenic SeNPs plays a direct role in the efﬁ-
cacious antimicrobial interaction with target bacterial plank-
tonic cells and bioﬁlms.
In conclusion, factors that are likely to concur in inﬂu-
encing the antimicrobial potential of biogenic metal/met-
alloid nanoparticles can be summarized as follows: (i)
the nature of constitutive elements (Natan and Banin,
2017); (ii) the size (Lu et al., 2013; Zonaro et al., 2015)
and (iii) the surface architecture (Verma and Stellacci,
2010). Much is still to be clariﬁed, however, in order to
elucidate in detail the nature of the external organic coat-
ing of biogenic metal nanoparticles for an actual interpre-
tation of the intimate biocidal mechanisms.
Finally, in order to investigate in depth the antibioﬁlm
activity of SeNPs already highlighted in previous ﬁndings
by the authors (Cremonini et al., 2016), the impact on
either bioﬁlm biomass or viability of bacterial cells embed-
ded in bioﬁlm extracellular polymeric substances (EPS)
was evaluated. With reference to the induction of consis-
tency loss of bioﬁlm biomass, untreated SeNPs were able
to signiﬁcantly disrupt the EPS matrix produced by all bac-
terial strains tested. Moreover, quantiﬁcation of culturable
cells trapped inside bacterial bioﬁlms conﬁrmed the bioci-
dal potential of untreated SeNPs, with a marked reduction
Fig. 4. Formation of ROS in P. aeruginosa, B. cenocepacia, S. au-
reus cells exposed to SeNPs for 24 h (SeNPs) normalized to cells
not exposed to NPs (Control) (n = 3; average  SEM; P < 0.05).
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in counts in ﬁve of the six strains tested, with the exception
of S. haemolyticus UST1, which instead retained cell via-
bility. Results from the tests carried out with differently
denatured SeNPs, compared to the untreated nanoparti-
cles, highlighted a progressively weaker effect on bioﬁlm
with a strength increase in denaturation treatments, con-
ﬁrming the key role played by the organic cap even in
terms of antibioﬁlm activity.
Although mechanisms through which metal/metalloid
nanoparticles exert antimicrobial activity are not com-
pletely understood, a number of authors claim the pro-
duction of reactive oxygen species (ROS) as one of the
possible modes of action (Manke et al., 2013; Yan et al.,
2013). In particular, antimicrobial effects of different sele-
nium compounds have been attributed to the formation
of free radicals (Tran et al., 2009). In this study, expo-
sure of three bacterial strains (namely P. aeruginosa
PAO1, S. aureus Mu50 and B. cenocepacia LMG16656)
to untreated SeNPs actually caused an increase in ROS
production compared to the controls. The amount of
ROS observed in our experiments is in the same order
of magnitude as those that were induced by some antibi-
otics (Van Acker et al., 2016) or by selenite alone
(Zonaro et al., 2015).
In conclusion, with the present investigation, evidence
has been found that biogenic SeNPs, synthesized by an
eco-friendly process can reasonably be considered a
reliable antimicrobial and antibioﬁlm agent capable of
efﬁcaciously inhibiting fastidious bioﬁlm-producing bacte-
ria of medical concern. Despite the formation of ROS,
which could contribute to the antiimicrobial activity of
SeNPs, features of the organic coat surrounding bio-
genic SeNPs were correlated to a marked inﬂuence on
the antimicrobial properties of those nanoparticles. The
external coating layer seems in fact to have a pivotal
role in hindering particle aggregation, maintaining
nanoparticles in a functional conformational state and
favouring their interaction with bacterial cells.
The information gained so far on biogenic SeNPs
opens a realistic perspective for a possible use of these
nanostructured particles as a novel non-antibiotic antimi-
crobial tool to treat challenging nosocomial infections,
including bioﬁlm-associated syndromes and diseased
states caused by multidrug-resistant bacteria. Further
investigations are, however, required to elucidate in
detail the actual mechanisms of action of these nanopar-
ticles as well to evaluate their whole biological compati-
bility with the human body.
Experimental procedures
Biosynthesis of biogenic SeNPs
Selenium nanoparticles were produced and puriﬁed from
Stenotrophomonas maltophilia SeITE02 culture after
24 h of growth in Nutrient Broth supplied with 0.5 mM
Na2SeO3.
The microbial culture was incubated in the dark at
27°C on a rotary shaker at 200 r.p.m. Bacterial cells and
SeNPs were removed from culture medium after 24 h by
centrifuging at 10 000 9 g for 10 min. The pellets were
washed twice with 0.9% NaCl solution, resuspended in
Tris/HCl buffer (pH 8.2), and cells were then disrupted
by ultrasonication at 100 W for 5 min. The suspension
was centrifuged at 10 000 9 g for 30 min to separate
disrupted cells (pellet) from SeNPs (supernatant). SeNPs
were recovered after centrifugation at 40 000 9 g for
30 min, washed twice and resuspended in deionized
water (Zonaro et al., 2015; Cremonini et al., 2016). The
SeNPs thus synthesized were indicated as SeNPs-24
and also as ‘untreated SeNPs’. The same experimental
protocol of preparation was applied using a microbial
culture incubated in the presence of 0.5 mM sodium
selenite for 48 h. The SeNPs obtained were indicated as
SeNPs-48.
Nanoparticle treatments and quantiﬁcation of proteins
and carbohydrates
Biogenic SeNPs were collected through centrifugation
at 16 000 r.p.m. and subsequently exposed to three dif-
ferent treatments: 10% SDS (treatment 1); 10% SDS
and boiling for 10 min (treatment 2); 10% SDS and
boiling for 30 min (treatment 3) (Dobias et al., 2011).
SeNPs were then centrifuged at 16 000 r.p.m., and the
supernatants were separated to quantify protein and
carbohydrate content obtained after different treatments.
The evaluation of proteins and carbohydrates was
applied also on untreated SeNPs and SeNPs-48. Pro-
tein concentration was determined following the method
of Lowry et al. (1951) using bovine serum albumin
(BSA) as standard; carbohydrates were measured using
the anthrone method (Roe, 1955) using glucose as
standard. Differences between the protein and carbohy-
drate content after treatments were determined using
one-way analysis of variance (ANOVA) with GRAPHPAD
PRISM 6.0 (GraphPad Software Inc., La Jolla, CA, USA).
The level of signiﬁcance was set at P < 0.05. All tests
were carried out in triplicate (n = 3), and the results
were averaged.
SeNPs-24, SeNPs-48 and SeNPs obtained after differ-
ent treatments were characterized by means of dynamic
light scattering (DLS) analysis. DLS was carried out
using a Zen 3600 Zetasizer Nano ZS (Malvern Instru-
ments, Malvern, UK) equipped with a 633-nm helium–
neon laser light source (4.0 mW), detecting scattering
information at a ﬁxed angle of 173°. SeNP samples
(300 ll) were transferred to a quartz cuvette (10 mm
path length), and the mean size distribution and zeta
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potential were recorded at 25°C using the software pro-
vided by Malvern Instruments.
Microbial strains and growth conditions
Experiments were conducted with both reference and
clinical strains. Speciﬁcally, we analysed four strains of
Pseudomonas aeruginosa, namely P. aeruginosa PAO1
(reference strain), INT (multi-resistant clinical isolate)
and BR1 and BR2 (both isolated from bronchial aspi-
rates), two clinical strains of Stenotrophomonas mal-
tophilia (S. maltophilia VR10 and VR20), Achromobacter
xyloxidans strain C and Burkholderia cenocepacia strain
LMG 16656. As far as Gram-positive bacterial strains,
we included in the study the methicillin-resistant Staphy-
lococcus aureus Mu50 strain (reference strain) and a
clinical strain isolated from an urine sample (S. aureus
UR1), as well as Staphylococcus epidermidis ET024,
isolated from a bioﬁlm on an endotracheal tube (Vande-
candelaere et al., 2014) and Staphylococcus haemolity-
cus UST1, a clinical isolate from a burn wound. All
bacterial strains were grown in Tryptone Soy Broth
(Oxoid, Basingstoke, England) at 37°C.
Determination of the minimum inhibitory concentration
(MIC) of biogenic NPs
The susceptibility of each strain to different types of
SeNPs was determined in triplicate according to the
National Committee for Clinical and Laboratory Stan-
dards (NCCLS) protocol using the broth microdilution
method in ﬂat-bottom 96-well microtiter plates. The
microbial inoculum was standardized to approximately
105 CFU ml1. Plates were incubated at 37°C for 24 h,
and the optical density (O.D.) at 590 nm was determined
using a multilabel microtiter plate reader (Envision, Per-
kin-Elmer LAS, Waltham, MA, USA). The MIC was
recorded as the lowest SeNP concentration at which no
signiﬁcant O.D. increase was observed.
Bioﬁlm formation and treatment
Polystyrene round-bottomed 96-well microtiter plates
were inoculated with 100 ll of a bacterial suspension
containing approximately 5 9 107 CFU ml1 and incu-
bated at 37°C for 4 h. The bioﬁlms formed were rinsed
once with 100 ll of physiological saline solution (PS) to
remove all non-adherent cells and subsequently treated
with 128 lg ml1 of the four different kinds of SeNPs
diluted in PS. For every strain, untreated bioﬁlms were
included as controls. Then, 100 ll of fresh medium was
added to each well and the plates were incubated for an
additional 20 h at 37°C (Peeters et al., 2008).
Quantiﬁcation of the bioﬁlm biomass (CV assay)
After 24 h of incubation, bioﬁlms were rinsed with 100 ll
PS and were ﬁxed by addition of 100 ll 99% methanol.
After an incubation of 15 min at room temperature, the
supernatant was removed and the plates were air-dried
at 37°C. Then, 100 ll of a 0.1% CV solution was added
to each well (20-min incubation at room temperature).
The dye-stained total bioﬁlm mass included live, dead
cells and extracellular polymeric substances (EPS)
grown on the bottom and the walls of microtiter plate
wells. The excess of CV was removed by washing the
plate under running tap water. Finally, 150 ll of 33%
acetic acid was added to resolubilize the stain and the
plate was put on a vortex for at least 20 min
(800 r.p.m.). The attached bacterial biomass was mea-
sured by evaluation of absorbance at 590 nm (Peeters
et al., 2008).
Quantiﬁcation of surviving cells
After 24 h of incubation, cells were collected by two
cycles of sonication and vortexing. The cell pellet
obtained after centrifugation (5 min at 13 000 r.p.m.)
was suspended in 1 ml of PS, and the number of col-
ony-forming units (CFU) was determined by plating on
TSA (Tryptone Soy Agar, Oxoid) (Peeters et al., 2008).
Measurement of ROS production
ROS production by bacterial cultures after treatment with
biogenic nanoparticles was investigated. The concentra-
tion of SeNPs used corresponded to the MIC for all
strains tested.
Overnight cultures of every strain were dispensed in
tubes, and 2-7-dichlorodihydroﬂuorescein diacetate
(H2DCF-DA, Sigma-Aldrich, Bornem, Belgium) was
added at a ﬁnal concentration of 10 lM. All tubes were
incubated for 1 h at 37°C and then centrifuged for
5 min at 13 000 r.p.m. Biogenic NPs were added to
two aliquots of cells (one with H2DCF-DA and one
without). Appropriate controls, to which an equal vol-
ume of PS was added instead of NPs, were also
included. All cell suspensions were transferred to a
black microtiter plate. Six wells were ﬁlled per condition.
The ﬂuorescence (kex = 485 nm and kem = 535 nm)
was measured every 30 min for approximately 24 h
with microtiter plate reader (Perkin-Elmer LAS). The net
ﬂuorescence emission by the NP-treated and NP-
untreated cells was calculated, and a corresponding
graph was created. The results are only comparable
within a plate and not between different plates (Wang
and Joseph, 1999).
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Statistical analysis
The data are expressed as means plus standard error
meaning (SEM). Statistical analyses, including t-test and
one-way analysis of variance (ANOVA), were performed
using GRAPHPAD PRISM 6.0 (GraphPad Software Inc., La
Jolla, CA, USA). All experiments were carried out in tripli-
cate. The level of signiﬁcance was set at P value <0.05.
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Supporting information
Additional Supporting Information may be found online in
the supporting information tab for this article:
Fig. S1. Diameter distribution of SeNPs extracted from
Stenotrophomonas maltophilia SeITE02. Biogenic SeNPs
(A), SeNPs after treatment with 10% SDS (B), SeNPs after
treatment with 10% SDS +10 min boiling (C), SeNPs after
treatment with 10% SDS + 30 min boiling (D).
Fig. S2. SeNPs-48: dynamic light scattering analysis and
zeta potential (A), diameter distribution (B), protein and car-
bohydrate concentrations (C), MIC (Minimum Inhibitory Con-
centration) values of SeNPs-48 against various bacterial
strains (D).
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